Lower Volume Likely to Hurt GE HealthCare's (GEHC) Q2 Earnings

Let's take a look at how things might have shaped up for GEHC prior to the announcement. Overall, imaging demand is healthy, especially for Molecular Imaging, Computed Tomography and Magnetic Resonance, supporting top-line growth. Moreover, the company completed the acquisition of MIM Software in April. GEHC added IM SurePlan and MIM Symphony families, MIM Maestro and MIM Encore, among others, to its product portfolio. These products are likely to have brought additional revenues during the soon-to-bereport ...